In a move the Food and Drug Administration itself called "a historic action," the agency has approved a treatment made by Novartis that uses a virus to genetically alter patients own white blood cells to battle a form of leukemia. The big question now: How much will it cost?
from Forbes Real Time //www.forbes.com/sites/matthewherper/2017/08/30/fda-approves-novartis-treatment-that-alters-patients-cells-to-fight-cancer/
via IFTTT
No comments:
Post a Comment